Jerrold B. Grossman - 27 May 2026 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Reporting relationship: Director
Issuer ticker: ADMA
Reported as of: 27 May 2026
Net transaction value: +$50,624
SEC form: 4
Accepted by SEC: 28 May 2026, 16:05:25 UTC
Prior SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dr. Jerrold B. Grossman, by Adam S. Grossman as Attorney-in-fact

Key filing fact

Jerrold B. Grossman filed Form 4 for ADMA BIOLOGICS, INC. (ADMA) on 28 May 2026.

Key facts

This page summarizes Jerrold B. Grossman's Form 4 filing for ADMA BIOLOGICS, INC. (ADMA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 May 2026, 16:05.

Change

Previous filing in this sequence was filed on 14 May 2026.
Current net transaction value: +$50,624.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001542519 Primary reporting owner

Grossman Jerrold B

Relationship: Director
Address: C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY
Signature: /s/ Dr. Jerrold B. Grossman, by Adam S. Grossman as Attorney-in-fact
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADMA transaction

Common Stock

Purchase

Transaction value: $50,624
Shares: +6,400
Change %: +1.2%
Price: $7.91
Shares after: 520,284
Date: 27 May 2026
Ownership: Direct
Footnotes: F1, F2

ADMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,857
Date: 27 May 2026
Ownership: See footnote
Footnotes: F3

ADMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 31,381
Date: 27 May 2026
Ownership: See footnote
Footnotes: F4

ADMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,294
Date: 27 May 2026
Ownership: See footnote
Footnotes: F5

ADMA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 175
Date: 27 May 2026
Ownership: See footnote
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents an open market purchase in a single transaction.

Footnote F2

Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 509,594 shares of common stock owned by the Reporting Person.

Footnote F3

These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood.

Footnote F4

These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.

Footnote F5

These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis.

Footnote F6

These shares are owned by the Reporting Person's wife.